Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Apr;84(7):926–935. doi: 10.1054/bjoc.2001.1698

Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions

L O Murphy 1, M W Cluck 1, S Lovas 1, F Ötvös 1, R F Murphy 1, A V Schally 2, J Permert 3, J Larsson 3, J A Knezetic 1, T E Adrian 1
PMCID: PMC2363846  PMID: 11286473

Abstract

In-vitro and in-vivo studies have shown that autocrine growth factors and receptors are frequently expressed in human malignancies. Few of these studies, however, provide evidence that the identified autocrine pathway is functional. In this study, a functional autocrine growth pathway in pancreatic cancer has been identified using an in-vitro cell culture system. When pancreatic cancer cells were grown without change of medium, proliferation was greater than when either medium was replaced frequently (HPAF, CAPAN-2, PANC-1 or SW1990) or cells were grown in the presence of the EGF receptor tyrosine kinase inhibitor AG1478 or the MEK inhibitor PD098059 (HPAF or CAPAN-2). Activity of extracellular-regulated kinases (ERK) 1 and 2 and c- jun and c- fos mRNA levels were significantly elevated in CAPAN-2 cells cultured continuously in serum-free medium. Collectively, the observations indicate that the EGF receptor and the ERK MAP kinase pathway mediate autocrine signals. In contrast to previous reports, the GRP and IGF-I receptors were shown not to be required for autocrine effects on pancreatic cancer cell proliferation. Autocrine stimulation of the EGF receptor can contribute to sustained mitogenic activity and proliferation of pancreatic cancer cells. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: autocrine, EGF-receptor, MAPK AP-1

Full Text

The Full Text of this article is available as a PDF (277.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanco-Aparicio C., Molina M. A., Fernández-Salas E., Frazier M. L., Mas J. M., Querol E., Avilés F. X., de Llorens R. Potato carboxypeptidase inhibitor, a T-knot protein, is an epidermal growth factor antagonist that inhibits tumor cell growth. J Biol Chem. 1998 May 15;273(20):12370–12377. doi: 10.1074/jbc.273.20.12370. [DOI] [PubMed] [Google Scholar]
  2. Cook P. W., Mattox P. A., Keeble W. W., Pittelkow M. R., Plowman G. D., Shoyab M., Adelman J. P., Shipley G. D. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol. 1991 May;11(5):2547–2557. doi: 10.1128/mcb.11.5.2547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ebert M., Yokoyama M., Kobrin M. S., Friess H., Lopez M. E., Büchler M. W., Johnson G. R., Korc M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res. 1994 Aug 1;54(15):3959–3962. [PubMed] [Google Scholar]
  4. Ebert M., Yokoyama M., Kobrin M. S., Friess H., Lopez M. E., Büchler M. W., Johnson G. R., Korc M. Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res. 1994 Aug 1;54(15):3959–3962. [PubMed] [Google Scholar]
  5. Funatomi H., Itakura J., Ishiwata T., Pastan I., Thompson S. A., Johnson G. R., Korc M. Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Int J Cancer. 1997 Jul 29;72(3):512–517. doi: 10.1002/(sici)1097-0215(19970729)72:3<512::aid-ijc21>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  6. Greenberg M. E., Ziff E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature. 1984 Oct 4;311(5985):433–438. doi: 10.1038/311433a0. [DOI] [PubMed] [Google Scholar]
  7. Hahn S. A., Schutte M., Hoque A. T., Moskaluk C. A., da Costa L. T., Rozenblum E., Weinstein C. L., Fischer A., Yeo C. J., Hruban R. H. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996 Jan 19;271(5247):350–353. doi: 10.1126/science.271.5247.350. [DOI] [PubMed] [Google Scholar]
  8. Hollande F., Imdahl A., Mantamadiotis T., Ciccotosto G. D., Shulkes A., Baldwin G. S. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology. 1997 Nov;113(5):1576–1588. doi: 10.1053/gast.1997.v113.pm9352860. [DOI] [PubMed] [Google Scholar]
  9. Howell G. M., Humphrey L. E., Ziober B. L., Awwad R., Periyasamy B., Koterba A., Li W., Willson J. K., Coleman K., Carboni J. Regulation of transforming growth factor alpha expression in a growth factor-independent cell line. Mol Cell Biol. 1998 Jan;18(1):303–313. doi: 10.1128/mcb.18.1.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Jayson G. C., Gallagher J. T. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells. Br J Cancer. 1997;75(1):9–16. doi: 10.1038/bjc.1997.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kobrin M. S., Funatomi H., Friess H., Buchler M. W., Stathis P., Korc M. Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun. 1994 Aug 15;202(3):1705–1709. doi: 10.1006/bbrc.1994.2131. [DOI] [PubMed] [Google Scholar]
  12. Korc M. Growth factors and pancreatic cancer. Int J Pancreatol. 1991 Summer;9:87–91. doi: 10.1007/BF02925583. [DOI] [PubMed] [Google Scholar]
  13. Kull F. C., Jr, Jacobs S., Su Y. F., Svoboda M. E., Van Wyk J. J., Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem. 1983 May 25;258(10):6561–6566. [PubMed] [Google Scholar]
  14. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  15. Landis S. H., Murray T., Bolden S., Wingo P. A. Cancer statistics, 1999. CA Cancer J Clin. 1999 Jan-Feb;49(1):8-31, 1. doi: 10.3322/canjclin.49.1.8. [DOI] [PubMed] [Google Scholar]
  16. Li Y. S., Shyy J. Y., Li S., Lee J., Su B., Karin M., Chien S. The Ras-JNK pathway is involved in shear-induced gene expression. Mol Cell Biol. 1996 Nov;16(11):5947–5954. doi: 10.1128/mcb.16.11.5947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lynch H. T., Smyrk T., Kern S. E., Hruban R. H., Lightdale C. J., Lemon S. J., Lynch J. F., Fusaro L. R., Fusaro R. M., Ghadirian P. Familial pancreatic cancer: a review. Semin Oncol. 1996 Apr;23(2):251–275. [PubMed] [Google Scholar]
  18. Mulder K. M., Brattain M. G. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. Mol Endocrinol. 1989 Aug;3(8):1215–1222. doi: 10.1210/mend-3-8-1215. [DOI] [PubMed] [Google Scholar]
  19. Ohmura E., Okada M., Onoda N., Kamiya Y., Murakami H., Tsushima T., Shizume K. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res. 1990 Jan 1;50(1):103–107. [PubMed] [Google Scholar]
  20. Osherov N., Levitzki A. Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem. 1994 Nov 1;225(3):1047–1053. doi: 10.1111/j.1432-1033.1994.1047b.x. [DOI] [PubMed] [Google Scholar]
  21. Otvös F., Murphy R. F., Lovas S. Coupling difficulty following replacement of Tyr with HOTic during synthesis of an analog of an EGF B-loop fragment. J Pept Res. 1999 Mar;53(3):302–307. doi: 10.1034/j.1399-3011.1999.00026.x. [DOI] [PubMed] [Google Scholar]
  22. Qin Y., Ertl T., Cai R. Z., Halmos G., Schally A. V. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro. Cancer Res. 1994 Feb 15;54(4):1035–1041. [PubMed] [Google Scholar]
  23. Qin Y., Ertl T., Cai R. Z., Horvàth J. E., Groot K., Schally A. V. Antagonists of bombesin/gastrin-releasing peptide inhibit growth of SW-1990 human pancreatic adenocarcinoma and production of cyclic AMP. Int J Cancer. 1995 Oct 9;63(2):257–262. doi: 10.1002/ijc.2910630219. [DOI] [PubMed] [Google Scholar]
  24. Quantin B., Breathnach R. Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts. Nature. 1988 Aug 11;334(6182):538–539. doi: 10.1038/334538a0. [DOI] [PubMed] [Google Scholar]
  25. Schuger L., Johnson G. R., Gilbride K., Plowman G. D., Mandel R. Amphiregulin in lung branching morphogenesis: interaction with heparan sulfate proteoglycan modulates cell proliferation. Development. 1996 Jun;122(6):1759–1767. doi: 10.1242/dev.122.6.1759. [DOI] [PubMed] [Google Scholar]
  26. Thurnher M., Radmayr C., Ramoner R., Ebner S., Böck G., Klocker H., Romani N., Bartsch G. Human renal-cell carcinoma tissue contains dendritic cells. Int J Cancer. 1996 Sep 27;68(1):1–7. doi: 10.1002/(SICI)1097-0215(19960927)68:1<1::AID-IJC1>3.0.CO;2-V. [DOI] [PubMed] [Google Scholar]
  27. Wagner M., Cao T., Lopez M. E., Hope C., van Nostrand K., Kobrin M. S., Fan H. U., Büchler M. W., Korc M. Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int J Cancer. 1996 Dec 11;68(6):782–787. doi: 10.1002/(SICI)1097-0215(19961211)68:6<782::AID-IJC16>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES